SCHEMBL18853319

SCHEMBL18853319

c1ccc(-c2ccc(-c3cccc(-c4cccc(-c5nc(-c6ccccc6)nc6sc7ccc8ccccc8c7c56)c4)c3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 3/20 0.39
▸ ADORA1 P30542 2/20 0.39
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ATM Q13315 2/20 0.35
▸ HPGD P15428 5/20 0.34
▸ SMN1; SMN2 Q16637 5/20 0.33
▸ RAB9A P51151 4/20 0.33
▸ MAPT P10636 4/20 0.33
▸ NPC1 O15118 3/20 0.33
▸ LMNA P02545 3/20 0.33
▸ F9 P00740 2/20 0.33
▸ RECQL P46063 1/20 0.33
▸ CYP1A1 P04798 1/20 0.33
▸ CYP1B1 Q16678 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ NFKB1 P19838 2/20 0.33
▸ NFKB2 Q00653 2/20 0.33
▸ RELA Q04206 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18853488 0.99 ADORA2A (0.39) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL18853497 0.99 ADORA2A (0.39) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL18853468 0.98 ADORA2A (0.39) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL18853413 0.96 ADORA2A (0.36) ADORA2AADORA1HPGDSMN1; SMN2RAB9A
SCHEMBL18853477 0.95 ADORA2A (0.36) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL18853416 0.94 ADORA2A (0.36) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL18853298 0.94 ADORA2A (0.36) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL18853466 0.94 ADORA2A (0.36) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL18853302 0.93 ADORA2A (0.36) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL18853490 0.92 MEN1 (0.40) ADORA2AADORA1MEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10680190-B2 Organic compound, organic optoelectronic element, and display device SAMSUNG SDI CO., LTD. (KR) 2020-06-09 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE OCIAD1, OXER1, OCIAD2 ADORA2A 3900/4885ADORA1 1978/4885MEN1 1335/4885
US-10680190-B2 Organic compound, organic optoelectronic element, and display device OCIAD1, OXER1, OCIAD2 ADORA2A 3900/4885ADORA1 1978/4885MEN1 1335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback